Absorption sites of orally administered drugs in the small intestine. (2nd December 2017)

• Record Type: Journal Article
• Authors: Murakami, Teruo
• Is Part Of: Expert opinion on drug discovery. Volume 12:Number 12(2017:Dec.)
• Page Start: 1219
• Page End: 1232
• Publication Date: 2017-12-02
• Subjects: Absorption site -- biopharmaceutical classification system (BCS) -- biopharmaceutics drug distribution classification system (BDDCS) -- permeability -- P-glycoprotein -- solubility -- transporter; 615.1
• DOI: 10.1080/17460441.2017.1378176
• Languages: English
• ISSNs: 1746-0441

Abstract

ABSTRACT: Introduction : In pharmacotherapy, drugs are mostly taken orally to be absorbed systemically from the small intestine, and some drugs are known to have preferential absorption sites in the small intestine. It would therefore be valuable to know the absorption sites of orally administered drugs and the influencing factors. Areas covered: In this review, the author summarizes the reported absorption sites of orally administered drugs, as well as, influencing factors and experimental techniques. Information on the main absorption sites and influencing factors can help to develop ideal drug delivery systems and more effective pharmacotherapies. Expert opinion: Various factors including: the solubility, lipophilicity, luminal concentration, pKa value, transporter substrate specificity, transporter expression, luminal fluid pH, gastrointestinal transit time, and intestinal metabolism determine the site-dependent intestinal absorption. However, most of the dissolved fraction of orally administered drugs including substrates for ABC and SLC transporters, except for some weakly basic drugs with higher pKa values, are considered to be absorbed sequentially from the proximal small intestine. Securing the solubility and stability of drugs prior to reaching to the main absorption sites and appropriate delivery rates of drugs at absorption sites are important goals for achieving effective pharmacotherapy.